United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Pharma Industry News The Max Foundation and Novartis deepen global cancer care partnerships with a pledge to reach 100,000 patients annually by 2030 The Max Foundation and Novartis pledge to expand global cancer care, targeting 100,000 patients annually by 2030 with systemic, equity-driven partnerships. bySoujanya RaviSeptember 24, 2025